GCP
INSP icon

Gill Capital Partners’s Inspire Medical Systems INSP Stock Holding History

Gill Capital Partners’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11
Closed -$567 – 711
2026
Q1 		$567 Buy
+11
New +$770 ﹤0.01% 626

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Gill Capital Partners's INSP Position: Q2 2026 in Review

Gill Capital Partners sold out of Inspire Medical Systems (INSP) in Q2 2026, closing a stake of 11 shares — an estimated $567 sold.

Gill Capital Partners first reported a position in INSP in Q1 2026 and held it in 1 quarter. The position peaked at $567 in Q1 2026. 276 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Gill Capital Partners reported no remaining Inspire Medical Systems position as of Q2 2026 after selling out during the quarter.
  • Gill Capital Partners sold 11 Inspire Medical Systems shares in Q2 2026, an estimated $567.
  • Gill Capital Partners first reported a position in Inspire Medical Systems in Q1 2026 and held it in 1 quarter.
  • Gill Capital Partners's Inspire Medical Systems position peaked at $567 in Q1 2026.
  • 276 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Gill Capital Partners's 13F filing for Q2 2026, filed 20 Aug 2026.